Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 1.00 |
| ▸ | CASP3 | P42574 | 1/20 | 1.00 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | NQO2 | P16083 | 1/20 | 0.63 |
| ▸ | APP | P05067 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10324933 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL15356596 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL3174845 | 0.86 | ALDH1A1 (0.76) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL3174841 | 0.86 | ALDH1A1 (0.76) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL27814166 | 0.86 | ALDH1A1 (0.75) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL9393619 | 0.84 | ALDH1A1 (0.72) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL9394660 | 0.84 | ALDH1A1 (0.72) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL8053522 | 0.84 | MAPT (0.72) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL18349235 | 0.84 | MAPT (0.72) | ALDH1A1MAPTMEN1KMT2AHPGD | |
| SCHEMBL8053519 | 0.84 | MAPT (0.72) | ALDH1A1MAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121362206-A | Fluorescent probe for detecting spermine and spermidine in water sample and urine, and preparation method and application thereof | 贵州大学 | 2026-01-20 | — | — | CN | disclosed |
| EP-2663307-B1 | ANTI-ANGIOGENIC COMPOUND | UNIV DUBLIN (IE) | 2016-08-31 | — | — | EP | disclosed |
| US-8916586-B2 | Anti-angiogenic compound | University College Dublin—National University of Ireland, Dublin (IE) | 2014-12-23 | — | — | US | disclosed |
| EP-2663307-A1 | ANTI-ANGIOGENIC COMPOUND | University College Dublin National University Of Ireland, Dublin (IE) | 2013-11-20 | — | — | EP | disclosed |
| US-20130289066-A1 | ANTI-ANGIOGENIC COMPOUND | UNIVERSITY COLLEGE DUBLIN - NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE) | 2013-10-31 | — | — | US | disclosed |
| WO-2012095836-A1 | ANTI-ANGIOGENIC COMPOUND | UNIVERSITY COLLEGE DUBLIN - NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE) | 2012-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130289066-A1 | ANTI-ANGIOGENIC COMPOUND | VEGFA, FLT4, FLT1 | ALDH1A1 1071/4885MAPT 2053/4885MEN1 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.